A systematic review to assess the 'treat-and-extend' dosing regimen for neovascular age-related macular degeneration using ranibizumab. [electronic resource]
Producer: 20180109Description: 1337-1344 p. digitalISSN:- 1476-5454
- Angiogenesis Inhibitors -- administration & dosage
- Drug Administration Schedule
- Humans
- Intravitreal Injections
- Ranibizumab -- administration & dosage
- Tomography, Optical Coherence
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
- Wet Macular Degeneration -- diagnosis
No physical items for this record
Publication Type: Journal Article; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.